Literature DB >> 1562664

Oxygen tensions and infections: modulation of microbial growth, activity of antimicrobial agents, and immunologic responses.

M K Park1, R A Myers, L Marzella.   

Abstract

Oxygen tensions play an important role in the outcome of infections. Oxygen is cidal or static for microorganisms that lack defenses against oxidants. Hyperoxia and hyperbaric oxygen exert antimicrobial effects by increasing the intracellular flux of reactive oxygen species. In bacteria, such species cause DNA strand breaks, degradation of RNA, inhibition of amino acid biosynthesis, and inactivation of membrane transport proteins. Oxygen tensions also affect the activity of antimicrobial agents. In general, hyperoxia potentiates while anaerobiosis decreases the activity of many antimicrobial drugs. With regard to host defenses, hyperoxia elevates oxygen tensions in infected tissues to levels that facilitate oxygen-dependent killing by leukocytes. Prolonged hyperoxia inhibits DNA synthesis in lymphocytes and impairs chemotactic activity, adherence, phagocytic capacity, and generation of the oxidative burst in polymorphonuclear leukocytes and macrophages.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1562664     DOI: 10.1093/clinids/14.3.720

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  40 in total

Review 1.  Wound microbiology and associated approaches to wound management.

Authors:  P G Bowler; B I Duerden; D G Armstrong
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

2.  Genetic and physiologic characterization of ferric/cupric reductase constitutive mutants of Cryptococcus neoformans.

Authors:  K J Nyhus; E S Jacobson
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

3.  Adjunctive therapies in the treatment of osteomyelitis.

Authors:  Robert C Fang; Robert D Galiano
Journal:  Semin Plast Surg       Date:  2009-05       Impact factor: 2.314

4.  Respiratory activity is essential for post-exponential-phase production of type 5 capsular polysaccharide by Staphylococcus aureus.

Authors:  B Dassy; J M Fournier
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

Review 5.  Staphylococcal adaptation to diverse physiologic niches: an overview of transcriptomic and phenotypic changes in different biological environments.

Authors:  Sana S Dastgheyb; Michael Otto
Journal:  Future Microbiol       Date:  2015-11-19       Impact factor: 3.165

6.  The SrrAB two-component system regulates Staphylococcus aureus pathogenicity through redox sensitive cysteines.

Authors:  Nitija Tiwari; Marisa López-Redondo; Laura Miguel-Romero; Katarina Kulhankova; Michael P Cahill; Phuong M Tran; Kyle J Kinney; Samuel H Kilgore; Hassan Al-Tameemi; Christine A Herfst; Stephen W Tuffs; John R Kirby; Jeffery M Boyd; John K McCormick; Wilmara Salgado-Pabón; Alberto Marina; Patrick M Schlievert; Ernesto J Fuentes
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-30       Impact factor: 11.205

7.  [Effects of hyperbaric oxygen therapy (HBO) during treatment of infected free bone transplants. A Case report].

Authors:  S Lentrodt; J Lentrodt
Journal:  Mund Kiefer Gesichtschir       Date:  2006-07

8.  Role of hyperbaric oxygen therapy in the treatment of postoperative organ/space sternal surgical site infections.

Authors:  Fabio Barili; Gianluca Polvani; Veli K Topkara; Luca Dainese; Faisal H Cheema; Maurizio Roberto; Moreno Naliato; Alessandro Parolari; Francesco Alamanni; Paolo Biglioli
Journal:  World J Surg       Date:  2007-08       Impact factor: 3.352

9.  Thioredoxin reductase is essential for thiol/disulfide redox control and oxidative stress survival of the anaerobe Bacteroides fragilis.

Authors:  Edson R Rocha; Arthur O Tzianabos; C Jeffrey Smith
Journal:  J Bacteriol       Date:  2007-09-14       Impact factor: 3.490

10.  Discovery and dissection of metabolic oscillations in the microaerobic nitric oxide response network of Escherichia coli.

Authors:  Jonathan L Robinson; Mark P Brynildsen
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.